Mild Asthma, a Revolutionary Therapy from Italian Research ( tion through publication in the NewEng...)

Mild Asthma, a Revolutionary Therapy from Italian Research

tion through publication in the New England Medical Journal”.

BEST is a multi-centre study (involving 8 Italian and 14 European centres), which enrolled 500 patients, monitored for 6 months. “Only sufferers who are considered mild persistent asthmatics according to current criteria were selected – explains Professor Alberto Papi, Head of the Clinic for respiratory tract illness at the University of Ferrara and assistant co-ordinator of the study. 60% of those involved in the study were suffering from allergic asthma. These are individuals who are well for most of the time, and for whom it is extremely difficult to guarantee that continuous therapy is followed as set out by current guidelines”.

“For nearly thirty years, the Chiesi Group has continuously developed the combination therapy involving bronchodilators and corticosteroids – comments Dr. Paolo Chiesi, Vice President and Head of the Italian company’s Research and Development division – Over time this initial perception has become an increasingly evident rationale and has gained significance in important clinical trials, such as the BEST study”.

“On the basis of our daily experience, – explains Dr. Germano Bettoncelli, Director of the respiratory area for the Società Italiana di Medicina Generale (Italian Society for General Medicine) – we can confirm that, when symptoms develop, most of the patients affected by this form of asthma tend to use the bronchodilator alone when required, or resort to a “DIY” drug combination, behaviour which to date has been tolerated even if it is “unorthodox”. We are therefore most certainly interested in the fact that data in support of treatment to be used when required is now emerging with the preconstituted combination of the two drugs, as this is a less burdensome and demanding therapeutic strategy&rd
'"/>

Page: 1 2 3
Related medicine technology :

1. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
2. Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
3. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
4. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
8. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
9. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
10. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
11. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

Post Your Comments:

(Date:5/24/2013)... Sinovac Biotech Ltd. (NASDAQ: SVA ... China , announced that Sinovac ... obtained the Certificate of Good Manufacturing Practices for ... and Food Administration (CFDA) for its proprietary vaccines, ... Changping filing and packaging facility. The GMP certificate ...

(Date:5/23/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...

(Date:5/23/2013)... , May 23, 2013 Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...

Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2 Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3 Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2

[0] Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines [0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland [0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference

... CHICAGO, Jan. 19, 2012 According to Marcia Crosse (Director, ... its mission to protect American health has been compromised. In ... on GAO,s High-Risk List, she says : ... in protecting the health of all Americans. FDA,s role is ...

... 2012 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... of 9,500,000 shares of its common stock at a ... gross proceeds to Neurocrine from this offering, before deducting ... by Neurocrine, are expected to be approximately $77 million. ...

Cached Medicine Technology:Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 2 Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 3 Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 4 Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 2 Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 3

Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight?Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock

(Date:5/25/2013)... (HealthDay News) -- Many viruses and parasites that affect ... -- a bacteria-borne illness than can result in liver ... parks, according to a veterinarian. These germs ... the air, said Dr. Susan Nelson, a clinical associate ... of these serious diseases can be fatal, even with ...

(Date:5/25/2013)... 2013 Providing patients with their best weight ... of weight management professionals. But, aside from educating patients on ... Doc’s hCG diets also provide patients, who have ... like bullying, more control over their lives by achieving their ... the underlying factors of weight gain derived from earlier abuse, ...

(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...

(Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...

(Date:5/25/2013)... 25, 2013 For college students, ... week. Increasingly, they are turning to prescription stimulants ... study. For more on this, go to ... facility, warns that students who pick up Adderall, ... risk for developing a physical and psychological dependency. ...

Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2

[0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals

... America and Merrill Lynch 2009 Health Care Conference on May ... May 19 -SAN DIEGO, May 6 Gen-Probe Incorporated (Nasdaq: ... present at the Bank of America and Merrill Lynch 2009 ... at approximately 9:20 a.m. Eastern time, and at the Deutsche ...

... Infotrieve, Inc. ( www.infotrieve.com ), the ... revolutionary software solution Content SCM(R) ... Science or Technology Service category of the 2009 CODiE ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080709/LAW008LOGO ...

... the 125,000-member Indiana American Legion today challenged the Indiana ... act plainly on behalf of the youngsters at the ... called on legislators to "not use the current budget ... plans announced by the Indiana State Department of Health, ...

... HOUSTON, May 6 Carriage Services, Inc. (NYSE: CSV ) today announced results for the first quarter ended March 31, 2009. ... Selected Financial Results , (amounts in millions, except per share amounts) , , ... Q1 Q1, ... 2009 Change, ...

... For Using A Knowledgeable Travel Advisor As The Swine ... The sudden outbreak of the H1N1 virus, more ... by surprise, causing opinions to become unsubstantiated rumors over ... luxury travel network, Virtuoso, has reached out to its ...

... First Quarter Highlights:- Revenue gained 7.5% to $187 ... 58.7% compared to Q1 2008, rising to $5.9 ... in client census and rate combined with increased ... from operations totaled $7.8 million- Sale of NET ...

Gen-Probe to Webcast Two Upcoming Investor Presentations Infotrieve's Content SCM(R) Wins 2009 CODiE Award Legion Demands 'Courage' From Legislators in Battle Over Children's Home Carriage Services Announces First Quarter 2009 Results Virtuoso(R) Affirms Travel Amidst H1N1 Flu Scare Providence Service Corporation Announces Record Revenues and Earnings in the First Quarter of 2009

High temperature loop tip cautery....

High temp cauteries, fine tip micro....

Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length....

6 mm, 45 degree upwards, detachable....

Medicine Products:

High Temperature Cauteries High Temp Cauteries Kerrison style punch Ferris-Smith Kerrison punches